• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

General determination of causation between Covid-19 vaccines and possible adverse events.

作者信息

Hampton Lee M, Aggarwal Rakesh, Evans Stephen J W, Law Barbara

机构信息

Gavi, the Vaccine Alliance, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland.

Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry 605006, India.

出版信息

Vaccine. 2021 Mar 5;39(10):1478-1480. doi: 10.1016/j.vaccine.2021.01.057. Epub 2021 Jan 29.

DOI:10.1016/j.vaccine.2021.01.057
PMID:33558107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7846216/
Abstract
摘要

相似文献

1
General determination of causation between Covid-19 vaccines and possible adverse events.新冠疫苗与可能的不良事件之间因果关系的一般判定
Vaccine. 2021 Mar 5;39(10):1478-1480. doi: 10.1016/j.vaccine.2021.01.057. Epub 2021 Jan 29.
2
Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review.接种 COVID-19 疫苗后的不良反应：一项叙述性综述。
Biomed Res Int. 2022 Aug 16;2022:2911333. doi: 10.1155/2022/2911333. eCollection 2022.
3
Global covid-19 vaccine rollout and safety surveillance-how to keep pace.全球新冠疫苗的推广与安全监测——如何跟上步伐。
BMJ. 2021 Jun 18;373:n1416. doi: 10.1136/bmj.n1416.
4
Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess.与 2019 年冠状病毒病（COVID-19）疫苗相关的预防接种不良事件：来自 VigiAccess 的描述性分析。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2109365. doi: 10.1080/21645515.2022.2109365. Epub 2022 Aug 10.
5
Reply to: correspondence on "Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis​".回复：关于“COVID-19疫苗接种后带状疱疹和单纯疱疹再激活：来自疫苗不良事件报告系统（VAERS）数据库分析的新见解”的通信
Expert Rev Vaccines. 2022 Aug;21(8):1161-1162. doi: 10.1080/14760584.2022.2070961. Epub 2022 May 17.
6
Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines.维多利亚专家免疫服务 (VicSIS) - 为 COVID-19 疫苗增强成人诊所。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2052701. doi: 10.1080/21645515.2022.2052701. Epub 2022 Apr 26.
7
The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.澳大利亚 COVID-19 疫苗的短期安全性：AusVaxSafety 主动监测，2021 年 2 月至 8 月。
Med J Aust. 2022 Aug 15;217(4):195-202. doi: 10.5694/mja2.51619. Epub 2022 Jul 4.
8
Preparing for COVID-19 vaccine safety surveillance: A United States perspective.为新冠病毒疫苗安全监测做准备：美国视角
Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1529-1531. doi: 10.1002/pds.5142. Epub 2020 Oct 2.
9
Serious adverse event following immunization and thromboembolic events associated with COVID19 vaccination: An analysis of nationwide causality assessment from India.接种后严重不良事件和与 COVID19 疫苗接种相关的血栓栓塞事件：来自印度全国因果关系评估的分析。
Indian Heart J. 2023 Mar-Apr;75(2):139-144. doi: 10.1016/j.ihj.2023.02.004. Epub 2023 Feb 28.
10
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.在报告 Janssen（强生）和 mRNA COVID-19 疫苗（辉瑞-生物科技和莫德纳）成年受种者发生不良事件后使用 COVID-19 疫苗：免疫实践咨询委员会的更新-美国，2021 年 7 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4.

引用本文的文献

1
Idiopathic granulomatous mastitis after mRNA vaccination against COVID-19: a possible association?新冠病毒mRNA疫苗接种后发生的特发性肉芽肿性乳腺炎：一种可能的关联？
BJR Case Rep. 2025 Feb 20;11(1):uaae048. doi: 10.1093/bjrcr/uaae048. eCollection 2025 Jan.
2
The WHO Algorithm for Causality Assessment of Adverse Effects Following Immunization with Genetic-Based Anti-COVID-19 Vaccines: Pitfalls and Suggestions for Improvement.世界卫生组织基于基因的抗COVID-19疫苗接种后不良反应因果关系评估算法：陷阱与改进建议
J Clin Med. 2024 Nov 30;13(23):7291. doi: 10.3390/jcm13237291.
3
A risk science perspective on vaccines.疫苗的风险科学视角。
Risk Anal. 2024 Dec;44(12):2780-2796. doi: 10.1111/risa.14228. Epub 2023 Sep 25.
4
Recent Advancement in mRNA Vaccine Development and Applications.mRNA疫苗开发与应用的最新进展
Pharmaceutics. 2023 Jul 18;15(7):1972. doi: 10.3390/pharmaceutics15071972.
5
Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis.贝尔麻痹与新冠疫苗：一项系统评价与荟萃分析
Vaccines (Basel). 2023 Jan 20;11(2):236. doi: 10.3390/vaccines11020236.
6
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.mRNA COVID-19 疫苗接种后在成人随机试验中特别关注的严重不良事件。
Vaccine. 2022 Sep 22;40(40):5798-5805. doi: 10.1016/j.vaccine.2022.08.036. Epub 2022 Aug 31.
7
mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2.mRNA 疫苗：如何应对 SARS-CoV-2 的挑战。
Front Immunol. 2022 Jan 21;12:821538. doi: 10.3389/fimmu.2021.821538. eCollection 2021.
8
Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder.新型冠状病毒2型疫苗神经及神经精神并发症因果关系评估的考量：从脑静脉窦血栓形成到功能性神经障碍
J Neurol Neurosurg Psychiatry. 2021 Nov;92(11):1144-1151. doi: 10.1136/jnnp-2021-326924. Epub 2021 Aug 6.
9
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?抗磷脂抗体与新冠病毒疫苗接种后血栓形成倾向风险：压垮骆驼的最后一根稻草？
Cytokine Growth Factor Rev. 2021 Aug;60:52-60. doi: 10.1016/j.cytogfr.2021.05.001. Epub 2021 May 28.

本文引用的文献

1
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.美国 2020 年 12 月 14 日至 23 日：在接种第一剂辉瑞-BioNTech COVID-19 疫苗后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.
2
Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.随着时间的推移，接种 AS03 佐剂大流行性 A/H1N1 流感疫苗（Pandemrix）后发生嗜睡症的风险变化，以及接种疫苗后发病日期定义的影响，在 2009 年 H1N1 流感大流行期间。
Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1045-1053. doi: 10.1002/pds.4788. Epub 2019 May 6.
3
Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.评价单价轮状病毒疫苗接种在非洲后的肠套叠。
N Engl J Med. 2018 Apr 19;378(16):1521-1528. doi: 10.1056/NEJMoa1713909.
4
Self controlled case series methods: an alternative to standard epidemiological study designs.自我对照病例系列方法：标准流行病学研究设计的替代方法
BMJ. 2016 Sep 12;354:i4515. doi: 10.1136/bmj.i4515.
5
International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.国际合作评估甲型 H1N1 流感 2009 单价疫苗接种后吉兰-巴雷综合征的风险。
Vaccine. 2013 Sep 13;31(40):4448-58. doi: 10.1016/j.vaccine.2013.06.032. Epub 2013 Jun 14.
6
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.在大规模式人群接种甲型 H1N1 流感疫苗时评估疫苗安全性时疾病背景发生率的重要性。
Lancet. 2009 Dec 19;374(9707):2115-2122. doi: 10.1016/S0140-6736(09)61877-8. Epub 2009 Oct 31.
7
Suspension of rotavirus vaccine after reports of intussusception--United States, 1999.1999年美国，在有肠套叠报告后停用轮状病毒疫苗。
MMWR Morb Mortal Wkly Rep. 2004 Sep 3;53(34):786-9.
8
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland.瑞士使用灭活鼻内流感疫苗与贝尔氏面瘫风险
N Engl J Med. 2004 Feb 26;350(9):896-903. doi: 10.1056/NEJMoa030595.
9
THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?环境与疾病：关联还是因果关系？
Proc R Soc Med. 1965 May;58(5):295-300. doi: 10.1177/003591576505800503.
10
Intussusception among infants given an oral rotavirus vaccine.口服轮状病毒疫苗的婴儿中的肠套叠。
N Engl J Med. 2001 Feb 22;344(8):564-72. doi: 10.1056/NEJM200102223440804.